{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:33:33Z","timestamp":1765546413301},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.vaccine.2019.01.035","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T16:12:02Z","timestamp":1549383122000},"page":"1350-1355","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax\u00ae23) in a healthy adult population and patients diagnosed with primary immunodeficiencies"],"prefix":"10.1016","volume":"37","author":[{"given":"Antony R","family":"Parker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshini S","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.01.035_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10875-013-9925-y","article-title":"Measurement of pneumococcal polysaccharide vaccine responses for immunodeficiency diagnostics: combined IgG responses compared to serotype specific IgG responses","volume":"34","author":"Janssen","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-6749(98)70089-2","article-title":"Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations","volume":"102","author":"Sorensen","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0020","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s10875-012-9856-z","article-title":"Quantification of IgM and IgA anti-pneumococcal capsular polysaccharides by a new ELISA assay: a valuable diagnostic and prognostic tool for common variable immunodeficiency","volume":"33","author":"Cavaliere","year":"2012","journal-title":"J Clin Immunol."},{"key":"10.1016\/j.vaccine.2019.01.035_b0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaci.2015.06.014","article-title":"Decreased IgM, IgA, and IgG response to pneumococcal vaccine in children with transient hypogammaglobulinemia of infancy","volume":"137","author":"Moschese","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.vaccine.2019.01.035_b0030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the basic and clinical immunology interest section of the american academy of allergy, asthma & immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.vaccine.2019.01.035_b0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/15321819.2017.1337641","article-title":"Concentrations of Pneumococcal IgA and IgM are compromised in some individuals with antibody deficiencies","volume":"38","author":"Echeverria de Carlos","year":"2017","journal-title":"J Immunoassay Immunochem"},{"key":"10.1016\/j.vaccine.2019.01.035_b0040","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/CDLI.10.5.744-750.2003","article-title":"Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides","volume":"10","author":"Biagini","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/CVI.00014-06","article-title":"Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assay","volume":"13","author":"Marchese","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1309\/781K5W6QH7JH2TMA","article-title":"A 22-plex chemiluminescent microarray for pneumococcal antibodies","volume":"128","author":"Pickering","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1309\/LMCH-C4Q2-VFL9-3T1A","article-title":"A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides","volume":"117","author":"Pickering","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2249.1993.tb07959.x","article-title":"The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK","volume":"93","author":"Hazlewood","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/CDLI.10.2.202-207.2003","article-title":"Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults","volume":"10","author":"Schauer","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0070","first-page":"108","article-title":"Comparison of 23- valent pneumococcal IgG ELISA with multiplex 13- valent serotype-specific antibody assay as diagnositc tools in subjects with suspected antibody deficiency","volume":"2","author":"Dziadzio","year":"2017","journal-title":"J Mol Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0075","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jaci.2011.01.035","article-title":"Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG","volume":"127","author":"Chua","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plabm.2016.02.004","article-title":"Concentration of anti-pneumococcal capsular polysaccharide IgM, IgG, IgA specific antibodies in adult blood donors","author":"Parker","year":"2016","journal-title":"Practical Laboratory Med"},{"key":"10.1016\/j.vaccine.2019.01.035_b0085","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s10875-012-9792-y","article-title":"Kinetics of IgM and IgA antibody response to 23-valent pneumococcal polysaccharide vaccination in healthy subjects","volume":"33","author":"Schutz","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0090","article-title":"Pneumococcal IgG-, IgA- and IgM-responses allow further distinction of patients with hypogammaglobulinemia","volume":"34","author":"Hanitsch","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0095","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1016\/j.vaccine.2015.09.041","article-title":"Antigen-specific IgA titres after 23-valent pneumococcal vaccine indicate transient antibody deficiency disease in children","volume":"33","author":"Janssen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.035_b0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00430-013-0292-3","article-title":"Reference ranges and cutoff levels of pneumococcal antibody global serum assays (IgG and IgG2) and specific antibodies in healthy children and adults","volume":"202","author":"Rose","year":"2013","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0105","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1081-1206(10)60572-8","article-title":"Assessment and clinical interpretation of polysaccharide antibody responses","volume":"99","author":"Paris","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.vaccine.2019.01.035_b0110","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/cis238","article-title":"Nomenclature for immune correlates of protection after vaccination","volume":"54","author":"Plotkin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.035_b0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.provac.2010.07.005","article-title":"Concepts of herd protection and immunity","volume":"2","author":"Smith","year":"2010","journal-title":"Procedia in Vaccinology"},{"key":"10.1016\/j.vaccine.2019.01.035_b0120","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1474-9726.2011.00732.x","article-title":"Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages","volume":"10","author":"Ademokun","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.vaccine.2019.01.035_b0125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/IAI.00768-10","article-title":"Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations","volume":"79","author":"Park","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.01.035_b0130","first-page":"51","article-title":"Immune responses to pneumococcal vaccines in children and adults: rationale for age-specific vaccination","volume":"3","author":"Westerink","year":"2012","journal-title":"Aging Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T17:23:07Z","timestamp":1606411387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19300982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0264410X19300982"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax\u00ae23) in a healthy adult population and patients diagnosed with primary immunodeficiencies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}